Economic and health burden of severe respiratory syncytial virus infection among hospitalised children at three tertiary hospitals in Argentina, Brazil, and Colombia: a two-year prospective multicentre cohort study
Open Access
- 21 August 2026
- journal article
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 63, 101601
Abstract
No abstract availableKeywords
Funding Information
- Merck
This publication has 50 references indexed in Scilit:
- Hospitalizations due to respiratory syncytial virus (RSV) infections in Germany: a nationwide clinical and direct cost data analysis (2010–2019)Infection, 2023
- Predictors of poor outcomes of respiratory syncytial virus acute lower respiratory infections in children under 5 years of age in a middle‐income tropical country based on the National Public Health Surveillance SystemPediatric Pulmonology, 2022
- Clinical impact and direct costs of nosocomial respiratory syncytial virus infections in the neonatal intensive care unitAmerican Journal of Infection Control, 2020
- Costs of Respiratory Syncytial Virus Hospitalizations in ColombiaPharmacoEconomics - Open, 2020
- Direct medical costs of RSV-related bronchiolitis hospitalizations in a middle-income tropical countryAllergologia et Immunopathologia, 2020
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Economic Evaluations of Occupational Health Interventions from a Company’s Perspective: A Systematic Review of Methods to Estimate the Cost of Health-Related Productivity LossJournal of Occupational Rehabilitation, 2010
- Comparing methodologies for the cost estimation of hospital servicesThe European Journal of Health Economics, 2008
- Cost-effectiveness analysis for multinational clinical trialsStatistics in Medicine, 2005
- Analysis of cost data in randomized trials: an application of the non-parametric bootstrapStatistics in Medicine, 2000